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excluded, and the majority of caval filters are still performed in
the angiography suite or operating room. However, since begin-
ning this program, we have found that the clinicians at our insti-
tution enjoy having this option available for selected patients at
risk for transportation complications.
We agree that comprehensive cost analysis is useful to assess
comparable techniques. The charge analysis showed no significant
difference, and a subsequent cost analysis of a second cohort demon-
strates that the bedside IVUS technique is less expensive. Neither of
these analyses account for lost opportunity for income in the operat-
ing room or angiography suite, which is likely to be significant.
The research protocol was designed with patient safety as a
primary concern, and aseptic techniques approved by the infec-
tion control director of our hospital were used. The thyroid drape
provides length to cover the foot of the bed and side rails, mini-
mizing the risk of contamination. No infections were experienced
in this series. Staff are familiar with aseptic techniques in the
intensive care unit because right heart catheterization, tra-
cheostomy, gastrostomy, abdominal packing changes, and other
more invasive operations are commonly performed when the rel-
ative risks of transportation outweigh bedside risks. Also, the
mobile cart includes backup inventory, and no procedure was
aborted because of catheter malfunction, contamination, or
unavailable supplies. It is important to emphasize planning before
undertaking these procedures.
Intravascular ultrasound scanning may detect some vena cava
abnormalities better than conventional imaging.1 If the anatomy
cannot be clearly defined with IVUS, we would opt for conven-
tional filter placement using fluoroscopy.
We are familiar with the innovative work of Hicks et al with
routine selective renal venography. However, this is not a stand-
ard practice in the placement of caval filters at our institution
because we are not aware of any demonstration of clinical efficacy
with these different techniques. Lastly, postprocedure radi-
ographs were performed in this study to assess positioning, and if
there is a patient with a maldeployed filter, we would recommend
corrective action under fluoroscopic guidance.
In summary, bedside vena cava filter placement is a useful
option for selected patients, although careful planning and famil-
iarity with the technique are important.
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Regarding “High endogenous estradiol is associated
with increased venous distensibility and clinical
evidence of varicose veins in menopausal women”
We read the article of Ciardullo et al (J Vasc Surg
2001;32:544-9) with great interest, and even more so the com-
ments by Georgiev.1 We agree with Georgiev in that just by meas-
uring estrogen levels, venous capacity, and the rate of varicose
veins, one cannot reach conclusions that “high serum levels of
estrogen induced increased venous distensibility” and that the
connection of this relationship to the incidence of varicose veins
cannot be firmly established based on Ciardullo’s findings. Since
Gregoriev’s letter, it has been shown with appropriate method
that female sex hormones increase venous distensibility.2-3 Since
the above studies also report that venous distensibility decreases
in animal models of menopause, and Ciardullo did not use a con-
trol group with normal cycle, we feel that any speculations for a
direct relationship between increased distensibility and an increase
in venous varicosity should be considered very cautiously.
Moreover, it can further confuse the interpretation of their results
on varicose veins and estrogen level in postmenopausal women
that they did not report the duration of varicose veins. It would
obviously make a big difference whether the menopausal patients
developed varicose veins 1 to 2 years before the study or 20 to 
30 years ago, as many women have varicose veins as early as their
first pregnancy.
Thomas Szaky, MD
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Gladstone, Manitoba, Canada
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The title of our paper defines very sharply our point of
view—we affirm that high endogenous estradiol is associated with
increased venous distensibility and clinical evidence of varicose
veins in menopausal women. To evaluate this association, we ana-
lyzed the cross-sectional data of the screenees for a trial on diet
and hormones.1 By indication our design is not conclusive to
demonstrate a causal relationship. We have compared groups of
menopausal women with different venous distensibility and
prevalence of varicose veins and have evaluated their endogenous
statements on causality; according to our findings, it is likely that
the residual estradiol level in menopausal women may play a role,
a starting point for new and specifically structured studies in
women.
We acknowledge the importance of the articles cited by Dr
Szaky. These studies have been carried out in ovariectomized rats
(not in women) and deal with hormone replacement and not with
endogenous hormones; in general, they point out results that we
should expect on the basis of our knowledge on the effect of
estrogen replacement on the venous system.
Dr Szaky’s observation that the absence of a comparison
group of women with normal cycle is the reason to be cautious
has no ground since there he presumes a comparison between
menopausal and premenopausal women, which certainly can
complicate rather than indicate the path to a causal relationship
evaluation.
